In vivo immunological function of mast cells derived from embryonic stem cells: an approach for the rapid analysis of even embryonic lethal mutations in adult mice in vivo.

An important goal of tissue engineering is to achieve reconstitution of specific functionally active cell types by transplantation of differentiated cell populations derived from normal or genetically altered embryonic stem cells in vitro. We find that mast cells derived in vitro from wild-type or genetically manipulated embryonic stem cells can survive and orchestrate immunologically specific IgE-dependent reactions after transplantation into mast cell-deficient Kit(W)/Kit(W-v) mice. These findings define a unique approach for analyzing the effects of mutations of any genes that are expressed in mast cells, including embryonic lethal mutations, in vitro or in vivo.

[1]  J. Mcdonald,et al.  Transplanted embryonic stem cells survive, differentiate and promote recovery in injured rat spinal cord , 1999, Nature Medicine.

[2]  R. McKay,et al.  Embryonic stem cell-derived glial precursors: a source of myelinating transplants. , 1999, Science.

[3]  G. Keller,et al.  Human embryonic stem cells: The future is now , 1999, Nature Medicine.

[4]  J. Kinet,et al.  The high-affinity IgE receptor (Fc epsilon RI): from physiology to pathology. , 1999 .

[5]  J. Gearhart.  New Potential for Human Embryonic Stem Cells , 1998, Science.

[6]  Jonathan A. Cooper,et al.  Multiple signaling pathways for the activation of JNK in mast cells: involvement of Bruton's tyrosine kinase, protein kinase C, and JNK kinases, SEK1 and MKK7. , 1998, Journal of immunology.

[7]  L. Zon,et al.  SEK1 deficiency reveals mitogen-activated protein kinase cascade crossregulation and leads to abnormal hepatogenesis. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[8]  G. Dranoff,et al.  Role for interleukin-3 in mast-cell and basophil development and in immunity to parasites , 1998, Nature.

[9]  T. Deacon,et al.  Blastula-Stage Stem Cells Can Differentiate into Dopaminergic and Serotonergic Neurons after Transplantation , 1998, Experimental Neurology.

[10]  H. Kohler,et al.  Hemato-lymphoid in vivo reconstitution potential of subpopulations derived from in vitro differentiated embryonic stem cells. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[11]  T. Ishizuka,et al.  Mast cell tumor necrosis factor α production is regulated by MEK kinases , 1997 .

[12]  M. Tsai,et al.  Differential release of mast cell interleukin-6 via c-kit. , 1997, Blood.

[13]  R. Flavell,et al.  Targeted disruption of the MKK4 gene causes embryonic death, inhibition of c-Jun NH2-terminal kinase activation, and defects in AP-1 transcriptional activity. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[14]  S. Galli,et al.  IgE Enhances Mouse Mast Cell FcεRI Expression In Vitro and In Vivo: Evidence for a Novel Amplification Mechanism in IgE-dependent Reactions , 1997, The Journal of Experimental Medicine.

[15]  G. Koh,et al.  Genetically selected cardiomyocytes from differentiating embronic stem cells form stable intracardiac grafts. , 1996, The Journal of clinical investigation.

[16]  S. Galli,et al.  Identification of a Committed Precursor for the Mast Cell Lineage , 1996, Science.

[17]  S. Orkin,et al.  In vitro differentiation of murine embryonic stem cells. New approaches to old problems. , 1996, The Journal of clinical investigation.

[18]  Z. S. Wang,et al.  Detection of mouse mast cell-associated protease mRNA. Heparinase treatment greatly improves RT-PCR of tissues containing mast cell heparin. , 1995, The American journal of pathology.

[19]  L. Zon,et al.  Activation of stress-activated protein kinase by MEKK1 phosphorylation of its activator SEK1 , 1994, Nature.

[20]  L. Zon,et al.  Role of SAPK/ERK kinase-1 in the stress-activated pathway regulating transcription factor c-Jun , 1994, Nature.

[21]  S. Galli,et al.  The kit ligand, stem cell factor. , 1994, Advances in immunology.

[22]  H. Metzger,et al.  Signal transduction by Fc receptors: the Fc&RI case , 1993 .

[23]  S. Galli,et al.  New concepts about the mast cell. , 1993, The New England journal of medicine.

[24]  M. Wiles,et al.  Hematopoietic commitment during embryonic stem cell differentiation in culture. , 1993, Molecular and cellular biology.

[25]  J. Gutiérrez-Ramos,et al.  In vitro differentiation of embryonic stem cells into lymphocyte precursors able to generate T and B lymphocytes in vivo. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[26]  M. Tsai,et al.  Induction of mast cell proliferation, maturation, and heparin synthesis by the rat c-kit ligand, stem cell factor. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[27]  M. Tsai,et al.  The rat c-kit ligand, stem cell factor, induces the development of connective tissue-type and mucosal mast cells in vivo. Analysis by anatomical distribution, histochemistry, and protease phenotype , 1991, The Journal of experimental medicine.

[28]  G. Keller,et al.  Multiple hematopoietic lineages develop from embryonic stem (ES) cells in culture. , 1991, Development.

[29]  E. Ortega,et al.  Mast cell stimulation by monoclonal antibodies specific for the Fcϵ receptor yields distinct responses of arachidonic acid and leukotriene C4 secretion , 1989, European journal of immunology.

[30]  S. Galli,et al.  125I-fibrin deposition in IgE-dependent immediate hypersensitivity reactions in mouse skin. Demonstration of the role of mast cells using genetically mast cell-deficient mice locally reconstituted with cultured mast cells. , 1987, Journal of immunology.

[31]  E. Robertson.  Teratocarcinomas and embryonic stem cells : a practical approach , 1987 .

[32]  E. Russell.  Hereditary anemias of the mouse: a review for geneticists. , 1979, Advances in genetics.

[33]  Y. Tanizaki,et al.  Basophils in bronchial asthma with reference to reagin‐type allergy , 1973, Clinical allergy.